uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Repeated venous sampling for determination of a gradient of fibroblast growth factor 23 for localization of an osteomalacia causing tumor
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Radiology, Oncology and Radiation Science, Radiology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences.
2011 (English)In: Acta Endocrinologica, ISSN 1841-0987, E-ISSN 1843-066X, Vol. 7, no 3, 395-403 p.Article in journal (Refereed) Published
Abstract [en]

Background: Oncogenic osteomalacia (OOM) is a rare syndrome caused by a tumor that produces a phosphaturic factor: fibroblast growth factor 23 (FGF23). These tumors can be extremely difficult to localize because they are small, slow growing and cause no local Symptoms.

Patient and methods: Venous sampling for detection of a gradient of FGF23 has been used to limit the area of further imaging. We describe a case of OOM in a 73-year old woman, with two years of spontaneous fractures, severe musculoskeletal pain and phosphate wasting.

Results: Her scrum FGF23 level was increased and whole-body intravenous sampling (11 sites) revealed a FGF23 gradient from the right leg. The second sampling indicated that the source of FGF23 was below the knee, but imaging studies, including magnetic resonance imaging and octreotide scintigraphy, were not conclusive. A third sampling demonstrated increasing FGF23 the more distal one came in the lower leg. Imaging of the forefoot finally identified a 10 mm tumor that was removed. Histopathological examination showed a phosphaturic mesenchymal tumor of mixed connective tissue type. The phosphate level and symptoms improved in days after surgery.

Conclusion: Repeated determinations of a venous gradient of FGF23 may be used to localize tumors of OOM.

Place, publisher, year, edition, pages
2011. Vol. 7, no 3, 395-403 p.
Keyword [en]
osteomalacia, oncogenic, FGF23, hypophosphatemia
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:uu:diva-160523DOI: 10.4183/aeb.2011.395ISI: 000295494000012OAI: oai:DiVA.org:uu-160523DiVA: diva2:451272
Available from: 2011-10-25 Created: 2011-10-25 Last updated: 2017-12-08Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Authority records BETA

Eklöf, Hampus

Search in DiVA

By author/editor
Eklöf, Hampus
By organisation
Department of Medical SciencesRadiology
In the same journal
Acta Endocrinologica
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 384 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf